Patents by Inventor Harlan E. Shannon

Harlan E. Shannon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions for treating pain
    Patent number: 6936601
    Abstract: The present invention provides compositions for treating pain using an atypical antipsychotic compound that is seroquel in combination with another Drug Used in the Treatment of Pain.
    Type: Grant
    Filed: August 15, 2002
    Date of Patent: August 30, 2005
    Assignee: Eli Lilly and Company
    Inventors: David Reed Helton, Harlan E. Shannon, Daniel E. Womer, Mary Jeanne Kallman
  • Method for treating pain
    Publication number: 20030013689
    Abstract: The present invention provides a method for treating pain using an atypical antipsychotic compound.
    Type: Application
    Filed: August 15, 2002
    Publication date: January 16, 2003
    Inventors: David Reed Helton, Harlan E. Shannon, Daniel E. Womer, Mary Jeanne Kallman
  • Method for treating pain
    Patent number: 6444665
    Abstract: The present invention provides a method for treating pain using an atypical antipsychotic compound.
    Type: Grant
    Filed: February 4, 2000
    Date of Patent: September 3, 2002
    Assignee: Eli Lilly and Company
    Inventors: David R. Helton, Harlan E. Shannon, Daniel E. Womer, Mary Jeanne Kallman
  • Method for treating schizophrenia
    Patent number: 6284771
    Abstract: The present invention provides a method for treating a condition selected from the group consisting of schizophrenia, schizoaffective disorder, and schizophreniform disorder in a patient using a Compound (I).
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: September 4, 2001
    Assignee: Eli Lilly and Company
    Inventors: Charles H. Mitch, Per Sauerberg, Harlan E. Shannon
  • Method for treating pain
    Patent number: 6258807
    Abstract: The present invention provides a method for treating pain comprising administering an analgesic dosage of olanzapine to an animal in need of such treatment.
    Type: Grant
    Filed: March 24, 1997
    Date of Patent: July 10, 2001
    Assignee: Eli Lilly and Company
    Inventors: David R. Helton, Harlan E. Shannon, Daniel E. Womer, Mary J. Kallman
  • Method for treating bipolar disorder
    Patent number: 6117890
    Abstract: The present invention provides a method for treating or alleviating the symptoms of bipolar disorder, comprising administering an effective amount of xanomeline (3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine) .
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: September 12, 2000
    Assignee: Eli Lilly and Company
    Inventors: Franklin P Bymaster, Harlan E Shannon
  • Method for treating excessive aggression
    Patent number: 6090829
    Abstract: The present invention provides a method of treating conduct disorder in a human using a compound of formula (I) ##STR1##
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: July 18, 2000
    Assignee: Eli Lilly and Company
    Inventors: Neil C Bodick, Franklin P Bymaster, Harlan E Shannon
  • Method for treating disruptive behavior disorders with xanomeline
    Patent number: 6043258
    Abstract: This invention relates to the use of xanomeline for the treatment of Disruptive Behavior Disorder and Attention Deficit Hyperactivity Disorder.
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: March 28, 2000
    Assignee: Eli Lilly and Company
    Inventors: Franklin P Bymaster, Harlan E Shannon
  • Method for treating mental retardation
    Patent number: 6034108
    Abstract: The present invention is directed to a method for using 3-(4-hexyloxy-1,2,5-thiadiazol-3yl)-1,2,5,6-tetrahydro-1-methylpyridine, i.e., xanomeline, for the treatment of autism and mental retardation.
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: March 7, 2000
    Assignee: Eli Lilly and Company
    Inventors: Franklin P Bymaster, Harlan E Shannon
  • Composition for treating pain
    Patent number: 5998434
    Abstract: The present invention provides a composition and method for treating pain using Selected Muscarinic Compounds and one or more compounds selected from the group consisting of Nonsteroidal Anti-inflammatory drugs, acetaminophen, opioids, and alpha-adrenergic compounds.
    Type: Grant
    Filed: June 4, 1998
    Date of Patent: December 7, 1999
    Assignee: Eli Lilly and Company
    Inventors: Charles H. Mitch, Harlan E. Shannon
  • Transdermal formulation of xanomeline
    Patent number: 5980933
    Abstract: The present invention provides a method for treating Alzheimer's Disease using a xanomeline transdermal formulation. The invention provides desired transdermal xanomeline patch formulations.
    Type: Grant
    Filed: September 29, 1997
    Date of Patent: November 9, 1999
    Assignee: Eli Liily and Company
    Inventors: Franklin Porter Bymaster, Michael Horstmann, Harlan E. Shannon, Lisa A. Shipley, Kirti H. Valia
  • Anesthetic method and composition
    Patent number: 5972932
    Abstract: The present invention provides a method for providing anesthesia using a composition comprising olanzapine and one or more opioids.
    Type: Grant
    Filed: March 24, 1997
    Date of Patent: October 26, 1999
    Assignee: Eli Lilly and Company
    Inventors: Mark J. Benvenga, Harlan E. Shannon
  • Antipsychotic method
    Patent number: 5968926
    Abstract: The present invention relates to a novel method for treating a mammal suffering from or susceptible to schizophrenia and schizophreniform diseases.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: October 19, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Franklin Porter Bymaster, Harlan E. Shannon, Per Sauerberg, Preben Olesen, John Stanley Ward, Charles H. Mitch
  • Method for treating pain
    Patent number: 5945416
    Abstract: The present invention provides a method for treating pain using a composition comprising olanzapine and Drug Useful in the Treatment of Pain.
    Type: Grant
    Filed: March 24, 1997
    Date of Patent: August 31, 1999
    Assignee: Eli Lilly and Company
    Inventors: Harlan E. Shannon, Daniel E. Womer
  • Method for treating migraine pain with olanzapine
    Patent number: 5929070
    Abstract: The present invention provides a method for treating migraine pain comprising administering an analgesic dosage of olanzapine.
    Type: Grant
    Filed: March 24, 1997
    Date of Patent: July 27, 1999
    Assignee: Eli Lilly and Company
    Inventors: Harlan E. Shannon, Daniel E. Womer
  • Method for treating anxiety with muscarinic cholinergic receptor agonists
    Patent number: 5888999
    Abstract: The present invention relates a method for treating anxiety using azacyclic and azabicyclic pyrazine compounds.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: March 30, 1999
    Assignee: Eli Lilly and Company
    Inventors: Neil C. Bodick, Franklin P. Bymaster, Walter W. Offen, Harlan E. Shannon
  • Transdermal formulation
    Patent number: 5858393
    Abstract: The present invention provides a method for treating a condition associated with muscarinic receptor modulation using a 3-?4-(butylthio)-1,2,5-thiadiazol-3-yl!-1-azabicyclo-?2.2.2!octane transdermal formulation. The invention provides desired transdermal 3-?4-(butylthio)-1,2,5-thiadiazol-3-yl!-1-azabicyclo?2.2.2!octane patch formulations.
    Type: Grant
    Filed: August 25, 1997
    Date of Patent: January 12, 1999
    Assignee: Eli Lilly and Company
    Inventors: Franklin Porter Bymaster, Harlan E. Shannon, Lisa A. Shipley, Kirti H. Valia
  • Method for treating anxiety
    Patent number: 5852036
    Abstract: The present invention provides a method for treating anxiety in humans using compounds which modulate a muscarinic receptor.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: December 22, 1998
    Assignee: Eli Lilly and Company
    Inventors: Neil C. Bodick, Franklin P. Bymaster, Walter W. Offen, Harlan E. Shannon
  • Method for treating anxiety
    Patent number: 5852037
    Abstract: The present invention provides a method for treating anxiety in humans using azacyclic or azabicyclic compounds.
    Type: Grant
    Filed: October 22, 1996
    Date of Patent: December 22, 1998
    Assignee: Eli Lilly and Company
    Inventors: Neil C. Bodick, Franklin P. Bymaster, Walter W. Offen, Harlan E. Shannon
  • Method for treating anxiety
    Patent number: 5763457
    Abstract: The present invention relates a method for treating anxiety using azacyclic and azabicyclic oxadiazole compounds.
    Type: Grant
    Filed: October 22, 1996
    Date of Patent: June 9, 1998
    Assignee: Eli Lilly and Company
    Inventors: Neil C. Bodick, Franklin P. Bymaster, Walter W. Offen, Harlan E. Shannon